Innovative CME/CE Technology

Unique Critique® is a real-time customizable, interactive, performance-improvement video program providing application-based training and subsequent review of comparative data to the learner, measuring peer-to-peer problem-solving. Up to 75 question and answer scenarios delivered throughout the video case-based learning allow participants to choose a customized learning path and continuously assess the participant during the activity rather than through passive post-program testing.

Using innovative technology, the faculty present(s) personalized video feedback to the participant based on selected answers, thereby providing multiple effective teachable moments. Each pathway is built upon principles of adult learning. Unique Critique provides the look and feel of a live lecture interfaced within a case-based question-answer format upon which a dynamic system captures continuous assessment data for comparative participant evaluation.

Evidence is presented by the expert to substantiate right and wrong decisions made by the user to maximize teachable moments Using a library of digital video clips, extensive branching logic and real-time participant input, the program is tailored to the participant’s individualized learning needs.

 

Featured Programs

New Enzyme Formulations for Managing Pancreatic Insufficiency in Cystic Fibrosis

Cystic Fibrosis

This program will discuss, compare and assess the evidence in therapeutic management of multiple sclerosis using interactive case-based learning technology. Attendees will receive a customized learning experience in a one-on-one question-and-answer format with expert faculty built upon case studies. Attendees will also be able to measure their answers against those of their peers. The program will provide information on immune modulating agents and their central role in MS management.
Read More

Case-Based Assessments in Therapeutic Management of Multiple Sclerosis

multiple sclerosis

This program will discuss, compare and assess the evidence in therapeutic management of multiple sclerosis using interactive case-based learning technology. Attendees will receive a customized learning experience in a one-on-one question-and-answer format with expert faculty built upon case studies. Attendees will also be able to measure their answers against those of their peers. The program will provide information on immune modulating agents and their central role in MS management.
Read More

Guidelines-Based Management of HPV & Cervical Cytological Abnormalities

HPV

New evidence for HPV testing and HPV diagnostics provides health care practitioners with improved techniques for detection of precancer. Knowledge of current guidelines for HPV testing and HPV diagnostics in women aged 30 and older is essential for practitioners in order to lower the risk of cervical cancer among their patients. This CME activity is intended to provide guidelines in the use of HPV testing and cervical cytological abnormalities.
Read More

New Therapies, New Competencies in Managing Patients with Opioid Therapy

Opioid

The role of the retail pharmacist in pain management is complex, including but not limited to monitoring and managing drug therapy, providing patient education, and providing drug information and education to other providers. When controlled substances are involved, the pharmacist is obligated to judge whether the prescription is legally valid and therapeutically appropriate. The emergence of pending therapeutic options in pain management will require the pharmacist to obtain accurate clinical updates.
Read More

Plotting a Course to Manage Inflammatory Bowel Disease

IBD

Inflammatory bowel disease (IBD) consists of 2 very distinct entities: Crohn’s disease and ulcerative colitis. Both conditions have severe symptoms, including abdominal cramping, diarrhea, and rectal bleeding. Both are also associated with a multitude of complications, including an increased risk of colon cancer in patients afflicted with the disease for long periods of time. Because these conditions can affect patients who are of working age, there is a disproportionate effect of IBD on younger patients and those enrolled in the workforce.
Read More

Plotting a Course to Manage Rheumatoid Arthritis

RA

Rheumatoid arthritis (RA) is a progressive, debilitating, and sometimes crippling condition which has a tremendous burden on society and the workforce. Patients with RA may suffer from complications related to joint pathology as well as organ dysfunction, including decreased immune system function, increased cardiovascular risk, and pulmonary complications. In light of this evidence, it is important to consider appropriate and early treatment of this condition.
Read More

One-On-One Expert Discussion About ACS Medication Management

ACS Medication Management

Approximately 64.4 million persons in the United States are affected with some form of cardiovascular disease, which includes hypertension, coronary heart disease, congestive heart failure, stroke, peripheral arterial disease, valvular heart disease and congenital cardiovascular defects. Cardiovascular disease is the number one killer in the US across all patients in all ethnic groups and costs the healthcare system more than $368 billion dollars in 2004 alone.
Read More

Case-Based Approaches to Managing Future Formularies for Immune Mediated Diseases

Immune Mediated Diseases

Case studies will be presented in disease states where a high incidence of cross-utility of biologic therapies is emerging as expanded indications for agents are rapidly occurring. Case studies will include rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, as these disease states invite the greatest discussion regarding a rapidly expanding group of biologic therapies...
Read More